Aqilion initiates collaboration with Immunscape

Aqilion searches for early innovative pharmaceutical projects thatare based on solid research resting on a firm biological foundation and offering both clinical relevance and patient benefit. Immunscape has developed innovative molecules…

New Associate Partners in P.U.L.S

The board elected today two new P.U.L.S. Associate Partners, Mats Pettersson and Professor Anders Vedin